Present Status of Chymopapain and Chemonucleolysis

Publisher Website
Google Scholar
Abstract
An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the FDA curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.

This publication has 0 references indexed in Scilit: